A Corticosteroid Program for Prevention of Hospitalization for Status Asthmaticus in Children
This study assessed the efficacy of an outpatient course of prednisone in the treatment of acute asthma, as a method of preventing hospitalization for status asthmaticus. From September-November 1984, 181 courses of prednisone were utilized by children for acute exacerbations of asthma inadequately controlled by bronchodilators and inhaled beclomethasone dipropionate or cromolyn. The dose of prednisone was 1 mg/kg/day for five days with a maximum of 40 mg/day. Only ten children required hospitalization for status asthmaticus. Privately insured patients and non-privately insured patients accounted for 61 and 120 of the prednisone courses, respectively, of which five children from each group required hospitalization.
The data suggest that short-term administration of prednisone for exacerbations of asthma was valuable in decreasing the need for hospitalization for asthma among bronchodilator-treated asthmatics. Further, patients from families without private hospitalization insurance appear as amenable to prednisone-intervention as privately insured patients.
The data suggest that short-term administration of prednisone for exacerbations of asthma was valuable in decreasing the need for hospitalization for asthma among bronchodilator-treated asthmatics. Further, patients from families without private hospitalization insurance appear as amenable to prednisone-intervention as privately insured patients.
Document Type: Research Article
Publication date: 01 March 1987
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma and by having the potential to directly impact the quality of patient care. AAP welcomes the submission of original works including peer-reviewed original research and clinical trial results. Additionally, as the official journal of the Eastern Allergy Conference (EAC), AAP will publish content from EAC poster sessions as well as review articles derived from EAC lectures.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service. - Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- Commercial level: Permission to use content
- www.JFoodAllergy.com
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content